Stock Track | Chemours Plunges 6.86% After-Hours on Earnings Miss and Widened Net Loss

Stock Track

Feb 20

Chemours (CC) shares plummeted 6.86% in after-hours trading on Thursday, following the release of the company's fourth-quarter and full-year 2025 financial results.

The sharp decline was driven by the company reporting earnings and sales that fell short of analyst expectations. For the fourth quarter, Chemours posted adjusted earnings per share of $0.05, missing the consensus estimate of $0.07. Quarterly sales of $1.300 billion also came in below the estimated $1.328 billion. Furthermore, the company reported a net loss attributable to shareholders of $47 million for the quarter, a significant increase from the $11 million loss a year earlier.

For the full year 2025, the company's adjusted EBITDA of $742 million slightly missed the estimate of $755.2 million, while adjusted EPS of $0.95 was just below the $0.96 forecast. Looking ahead, Chemours provided guidance for fiscal year 2026, projecting net sales growth of 3% to 5% and adjusted EBITDA in the range of $800 million to $900 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1127595660"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1127595660\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1127595660?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 05:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127595660","market":"nz","top_or_hot":-1,"title":"Stock Track | Chemours Plunges 6.86% After-Hours on Earnings Miss and Widened Net Loss","media":"Stock Track","content":"<p>Chemours (CC) shares plummeted 6.86% in after-hours trading on Thursday, following the release of the company's fourth-quarter and full-year 2025 financial results.</p><p>The sharp decline was driven by the company reporting earnings and sales that fell short of analyst expectations. For the fourth quarter, Chemours posted adjusted earnings per share of $0.05, missing the consensus estimate of $0.07. Quarterly sales of $1.300 billion also came in below the estimated $1.328 billion. Furthermore, the company reported a net loss attributable to shareholders of $47 million for the quarter, a significant increase from the $11 million loss a year earlier.</p><p>For the full year 2025, the company's adjusted EBITDA of $742 million slightly missed the estimate of $755.2 million, while adjusted EPS of $0.95 was just below the $0.96 forecast. Looking ahead, Chemours provided guidance for fiscal year 2026, projecting net sales growth of 3% to 5% and adjusted EBITDA in the range of $800 million to $900 million.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Chemours Plunges 6.86% After-Hours on Earnings Miss and Widened Net Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Chemours Plunges 6.86% After-Hours on Earnings Miss and Widened Net Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-20 05:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Chemours (CC) shares plummeted 6.86% in after-hours trading on Thursday, following the release of the company's fourth-quarter and full-year 2025 financial results.</p><p>The sharp decline was driven by the company reporting earnings and sales that fell short of analyst expectations. For the fourth quarter, Chemours posted adjusted earnings per share of $0.05, missing the consensus estimate of $0.07. Quarterly sales of $1.300 billion also came in below the estimated $1.328 billion. Furthermore, the company reported a net loss attributable to shareholders of $47 million for the quarter, a significant increase from the $11 million loss a year earlier.</p><p>For the full year 2025, the company's adjusted EBITDA of $742 million slightly missed the estimate of $755.2 million, while adjusted EPS of $0.95 was just below the $0.96 forecast. Looking ahead, Chemours provided guidance for fiscal year 2026, projecting net sales growth of 3% to 5% and adjusted EBITDA in the range of $800 million to $900 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CC","symbol_name":"Chemours Company","start_time":0,"source_url":"","article_id":"1127595660","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127595660","pubTimestamp":1771537616,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Chemours (CC) shares plummeted 6.86% in after-hours trading on Thursday, following the release of the company's fourth-quarter and full-year 2025 financial results.The sharp decline was driven by the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CC":"Chemours Company"},"translate_title":"个股追踪|科慕盘后暴跌6.86%财报不及净亏损扩大","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CC":1},"content_text":"Chemours (CC) shares plummeted 6.86% in after-hours trading on Thursday, following the release of the company's fourth-quarter and full-year 2025 financial results.The sharp decline was driven by the company reporting earnings and sales that fell short of analyst expectations. For the fourth quarter, Chemours posted adjusted earnings per share of $0.05, missing the consensus estimate of $0.07. Quarterly sales of $1.300 billion also came in below the estimated $1.328 billion. Furthermore, the company reported a net loss attributable to shareholders of $47 million for the quarter, a significant increase from the $11 million loss a year earlier.For the full year 2025, the company's adjusted EBITDA of $742 million slightly missed the estimate of $755.2 million, while adjusted EPS of $0.95 was just below the $0.96 forecast. Looking ahead, Chemours provided guidance for fiscal year 2026, projecting net sales growth of 3% to 5% and adjusted EBITDA in the range of $800 million to $900 million.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}